Urinary incontinence is common among women. One quarter of young women, half of middle aged women, and three quarters of older women experience involuntary urine loss. Although a common problem, not many women feel comfortable talking about it.
Over $19.5 billion is spent each year on treatments, ranging from behavioral modification, physical therapy, medication, and surgery. Now there is the O-Shot. The Shot is meant for the 15 percent of women with stress incontinence – leakage from strain like sneezing or lifting. The O-Shot was developed by Louisiana doctor Charles Runels, who also created the “vampire face-lift” used by Kim Kardashian. The shot, an injection of platelet-rich plasma made from the patient’s blood, is claimed to help with incontinence.
Women are desperate to solve this embarrassing issue. Numerous doctors across the country are listed on Runels’ website oshot.info. The therapy has been used for 20 years for pain in joints, sports injuries, and wound healing. The plasma stimulates cells to increase collagen and elastin. By regenerating tissue, it helps stress incontinence.
Blood is drawn from the patient and placed in a centrifuge to separate the red blood cells from plasma. After topical numbing and a local anesthetic, four cc’s of plasma is injected into the interior vaginal wall and 1 cc directly into the clitoris.
Improvement is not immediate. There is a 65 percent success rate after three months. If the patient has not experienced success after three months, a second shot can be given. The second treatment has a 85 percent success rate. Runels recommends a yearly injection for maintenance. A single treatment costs $1,500 and is not covered by insurance.
Although the O-Shot is advertised as a treatment for several genitourinary problems, there is not yet any peer-reviewed scientific evidence or FDA approval. It is still a very new treatment for incontinence.
Rush, Ilene Raymond. “The O-Shot: Incontinence fix or empty promise?” Health. Philly.com, 15 Jun 2017. Web. 15 Jun 2017.